Bioethics in Perspective: Corporate Power, Public Health and Political EconomyPaperback
Free delivery worldwide
Dispatched in 1 business day
When will my order arrive?
- Publisher: CAMBRIDGE UNIVERSITY PRESS
- Format: Paperback | 294 pages
- Dimensions: 173mm x 244mm x 18mm | 544g
- Publication date: 6 September 2010
- Publication City/Country: Cambridge
- ISBN 10: 0521756561
- ISBN 13: 9780521756563
- Sales rank: 544,112
In Bioethics in Perspective Scott Mann demonstrates the importance of issues of corporate power, global inequality and sustainability in shaping health outcomes around the world. The text develops a comprehensive ethical and practical critique of the neoliberal economic ideas which have guided policy in the English-speaking world. It explores the consequences of such policies for health and healthcare around the world, in terms of increasing health inequalities, serious food and water shortages, inadequate health care provision and the marketing of dangerous and unnecessary drugs. With clear proposals for political and economic reform to effectively address these problems, Bioethics in Perspective provides an important counterbalance to much conventional commentary on bioethics. It takes readers with little or no prior knowledge of ethics, economics or medicine quickly and easily into advanced debates and discussions about the causes and consequences of health and illness around the world.
Other people who viewed this bought:
USD$32.61 - Save $2.28 (6%) - RRP $34.89
USD$128.02 - Save $20.45 13% off - RRP $148.47
USD$38.37 - Save $6.17 13% off - RRP $44.54
Other books in this category
USD$31.28 - Save $13.19 29% off - RRP $44.47
USD$14.19 - Save $5.10 26% off - RRP $19.29
USD$12.81 - Save $4.27 24% off - RRP $17.08
USD$9.64 - Save $4.36 31% off - RRP $14.00
USD$11.52 - Save $7.77 40% off - RRP $19.29
Scott Mann BA Hons (Sussex), MPhil (Sussex), PhD (Sydney) is Associate Professor, School of Law, University of Western Sydney.
Table of contents
Introduction; 1. Ethics and ideology; 2. Freely competitive markets; 3. Problems of competition; 4. Health inequalities; 5. Food and water; 6. GM foods and life patents; 7. Energy and greenhouse; 8. Healthcare provision; 9. Drugs, drug-testing and drug companies; 10. What is to be done.